Seeing Is Believing
Healthcare - Sector
TGTX is currently covered by 4 analysts with an average price target of $49.25. This is a potential upside of $12.34 (-9.25%) from yesterday's end of day stock price of $54.27.
TG Therapeutics's activity chart (see below) currently has 100 price targets and 113 ratings on display. The stock rating distribution of TGTX is 75% BUY, 12.5% HOLD and 12.5% SELL.
Analysts average stock forecasts to be materialized ratio is 77.49% with an average time for these price targets to be met of 430.73 days.
Highest price target for TGTX is $77, Lowest price target is $20, average price target is $49.25.
Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 13-Jul-2026. First documented stock forecast 22-Jul-2014.
Currently out of the existing stock ratings of TGTX, 6 are a BUY (75%), 1 are a HOLD (12.5%), 1 are a SELL (12.5%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Oct-2025
$77
$22.73 (41.88%)
$70
Sell Since 21-May-2022
$20
$-34.27 (-63.15%)
$11
Hold Since 03-Aug-2023
$39
$-14.22 (-26.72%)
$37
Buy Since 27-Nov-2019
$55
$-0.83 (-1.49%)
$53
Buy Since 26-Jun-2023
$46
$-9.83 (-17.61%)
$40
What is TGTX (TG Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on TGTX (TG Therapeutics) with a proven track record?
Which analyst has the most public recommendations on TGTX (TG Therapeutics)?
Which analyst is the currently most bullish on TGTX (TG Therapeutics)?
Which analyst is the currently most reserved on TGTX (TG Therapeutics)?